Fever, shock, and pancytopenia in a patient treated with alemtuzumab

Clin Infect Dis. 2009 Nov 15;49(10):1540; 1616-7. doi: 10.1086/644730.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / adverse effects*
  • Antibodies, Neoplasm / therapeutic use*
  • Female
  • Fever / etiology
  • Humans
  • Lymphohistiocytosis, Hemophagocytic / chemically induced*
  • Lymphohistiocytosis, Hemophagocytic / diagnosis*
  • Lymphohistiocytosis, Hemophagocytic / pathology
  • Lymphohistiocytosis, Hemophagocytic / physiopathology
  • Middle Aged
  • Mycobacterium tuberculosis / isolation & purification
  • Pancytopenia / etiology
  • Shock / etiology
  • Tuberculosis / complications*
  • Tuberculosis / drug therapy*
  • Tuberculosis / pathology
  • Tuberculosis / physiopathology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Alemtuzumab